Global Topical Pain Relief Market Size, Share, and COVID-19 Impact Analysis, By Type (Prescription Pain Relief and Over-the-Counter (OTC) Pain Relief), By Distribution Channel (Pharmacy and Drug Stores, Retail Stores, and Online Stores), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Topical Pain Relief Market Insights Forecasts to 2033

• The Global Topical Pain Relief Market Size was estimated at USD 10.47 Billion in 2023
• The Global Topical Pain Relief Market Size is Expected to Grow at a CAGR of around 5.06% from 2023 to 2033
• The Worldwide Topical Pain Relief Market Size is Expected to Reach USD 17.16 Billion by 2033
• Asia Pacific is expected to grow the fastest during the forecast period.

The Global Topical Pain Relief Market Size is expected to cross USD 17.16 Billion by 2033, growing at a CAGR of 5.06% from 2023 to 2033. One important trend in the topical pain treatment market is the continuous advancement of drug delivery technologies, which are essential for improving the effectiveness of topical pain relief products.    

Market Overview  

The healthcare sector devoted to the creation, manufacturing, and distribution of products for topical pain relief is known as the topical pain relief market. To relieve pain from a variety of ailments, including sports injuries, sprains, arthritis, and back pain, these products are usually administered directly to the skin. Products in the topical pain management market include creams, gels, ointments, patches, and sprays with active components such as non-steroidal anti-inflammatory medications (NSAIDs), menthol, capsaicin, or lidocaine. The world's aging population and athletes' growing need for topical pain management are two factors driving the topical pain relief market. The demand for targeted pain management solutions is being driven by the growing prevalence of musculoskeletal illnesses, arthritis, and back pain, which is driving the market for topical pain relief. The aging population, which is more susceptible to diseases including osteoarthritis, joint pain, and other musculoskeletal ailments, is driving the growth of the topical pain relief market.      

Report Coverage

This research report categorizes the topical pain relief market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the topical pain relief market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the topical pain relief market.

Driving Factors

The increasing prevalence of chronic pain diseases including back pain and arthritis, the growing need for non-invasive treatment choices, and increased knowledge about the advantages of topical therapies are the main factors driving the market for topical pain relief. The rise in the frequency of bone-related disorders such as diabetic neuropathy and arthritis is a prominent factor driving the market for topical pain relief. The increase in the global geriatric population, the growing demand for topical pain relief by athletes, and the growing use of topical pain relief products due to their less adverse effects than oral pain relief are other factors driving the growth of the topical pain relief market.      

Restraining Factors

The topical pain relief market expansion is restricted by several factors, such as the unpleasant odor or smell of topical painkillers and the possibility of skin irritation.     

Market Segmentation

The topical pain relief market share is classified into type and distribution channel.       

• The over-the-counter (OTC) pain relief segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.

Based on the type, the topical pain relief market is divided into prescription pain relief and over-the-counter (OTC) pain relief. Among these, the over-the-counter (OTC) pain relief segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The demand for easily available and practical remedies for mild pain disorders is met by the over-the-counter (OTC) pain relief market. These treatments, which include patches, gels, and lotions, are frequently used to provide short-term relief from moderate arthritis, sprains, and muscle aches.   

• The online stores segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.  

Based on the distribution channel, the topical pain relief market is divided into pharmacy and drug stores, retail stores, and online stores. Among these, the online stores segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. Online stores are popular due to their user-friendliness, wide range of products, and competitive pricing. These platforms provide easy access to a wide range of products, allowing customers to weigh their options and make informed decisions from the comfort of their homes.  

Regional Segment Analysis of the Topical Pain Relief Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the topical pain relief market over the predicted timeframe.

North America is anticipated to hold the largest share of the topical pain relief market over the predicted timeframe. Numerous variables, such as a high prevalence of chronic pain conditions, an advanced healthcare system, and growing investments in research and development (R&D), support North America market growth. The widespread usage of over-the-counter medications and the availability of prescription-based substitutes expand the range of topical pain relief options available to consumers. The demand for effective pain treatment techniques is increased by the region's aging population, which also adds to the rising incidence of conditions including arthritis and musculoskeletal illnesses.   

Asia Pacific is expected to grow at the fastest CAGR growth of the topical pain relief market during the forecast period. The market for topical pain relief is being driven in the Asia-Pacific (APAC) region by the increased prevalence of musculoskeletal illnesses and the increased demand for non-invasive pain management solutions.  The Asia Pacific region has a sizable population, which naturally results in a strong need for topical pain relievers. Additionally, rising disposable income in the region increases consumer spending power and drives market expansion.    

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the topical pain relief market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

List of Key Companies

• Advacare Pharma
• Novartis AG
• Reckitt Benckiser Group Plc
• Mylan N.V.
• Johnson & Johnson
• Exzell Pharma Inc.
• Pfizer Inc.
• Sanofi S.A.
• Glaxosmithkline Plc
• Topical Biomedics Inc
• Endo International plc
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Limited
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In September 2024, Mankind Pharma has launched Nimulid Strong, a topical analgesic gel and spray with 2X diclofenac concentration, targeting neck pain relief. The product is backed by the GardanHilaateRaho campaign, highlighting the importance of neck mobility in communication.
• In August 2024, Advil introduced its initial topical pain relief product, Advil Targeted Relief. This cream features four powerful pain-relieving ingredients to provide quick, focused relief for as long as 8 hours. It tackles issues like back pain, muscle soreness, sprains, strains, and arthritis, offering an over-the-counter remedy for efficient pain relief.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the topical pain relief market based on the below-mentioned segments: 

Global Topical Pain Relief Market, By Type  

• Prescription Pain Relief
• Over-the-Counter (OTC) Pain Relief

Global Topical Pain Relief Market, By Distribution Channel  

• Pharmacy and Drug Stores
• Retail Stores
• Online Stores

Global Topical Pain Relief Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa